Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Overview

In recent history, we have witnessed the emergence of several different life-threatening viruses. In addition to causing serious public health concerns around the globe, they have been responsible for significant human morbidity and mortality. Modern life that entails uncurtailed travel of humans and goods means that initially localized outbreaks may pose a risk of transmission anywhere in the world.

One of these novel viruses implicated in severe acute illness was Middle East respiratory syndrome coronavirus (MERS-CoV), a close relative of the severe acute respiratory syndrome coronavirus (SARS-CoV). Due to its high fatality rate, the discovery has had a dual effect: fear of contracting it among the public, and a potential burden on the healthcare system.

MERS Virus Outbreak: Everything You Need to Know

The Origin of MERS-CoV

MERS-CoV was initially identified in the Kingdom of Saudi Arabia in the summer of 2012, having been isolated from the sputum sample of a 60-year-old man presenting with community acquired pneumonia. He subsequently developed a fatal disease associated with respiratory failure and acute renal failure.

Shortly thereafter, this new illness was found to have an earlier point of onset, in April 2012 when there was a small outbreak of pneumonia among healthcare workers in a single Jordanian hospital intensive care unit. Two of the patients in this cluster died. They were later discovered to have the MERS-CoV in a retrospective analysis of stored tissue samples.

This new infection had a disconcertingly high morbidity and mortality. It is true that in a small fraction of cases the disease was mild, but the majority of patients exhibited an acute and serious respiratory illness that required hospitalization, and which ended in a fatal outcome in nearly six out of ten patients.

Virology of MERS-CoV

Coronaviruses are a group of enveloped RNA viruses of the family Coronaviridae. Their surface appearance resembles that of a crown under the electron microscopy, which has given rise to their scientific name (Latin “corona” meaning “crown” or “halo”). Coronaviruses able to infect humans are shown to emerge via cross-host transmission from animals.

MERS-CoV is a lineage C betacoronavirus that is found in humans and camels. This virus is different from the other human betacoronaviruses (such as SARS-CoV, HKU1 and OC43). It is closely linked to some bat coronaviruses (such as BtCoV-HKU4 or BtCoV-HKU5). This is why it is believed that MERS-CoV (like a plethora of other coronaviruses) originated in bats.

Dipeptidyl peptidase 4 (or DPP4) is a functional protein receptor for MERS-CoV that enables the infection, and it is found on the surfaces of non-ciliated epithelial cells in human bronchi. This receptor shows high level of amino acid sequence conservation between different species, including the bat cells.

Reaching the Consensus in Naming

Since it was first discovered, isolates of MERS-Cov have appeared in the medical literature under different names (such as human betacoronavirus 2c EMC, human betacoronavirus 2C Jordan-N3, human betacoronavirus 2c England-Qatar or betacoronavirus England 1). However, the term “novel coronavirus (NCoV)” has appeared most frequently.

After careful deliberation and extensive consultation, the Coronavirus Study Group (a part of the International Committee on Taxonomy of Viruses) resolved on the name Middle East respiratory syndrome coronavirus (or MERS-CoV) for the new coronavirus. This name was finally accepted by the scientists who discovered and worked on the virus, as well as by the Saudi Arabian Ministry of Health and the World Health Organization (WHO).


  1. http://jvi.asm.org/content/87/14/7790.long
  2. https://www.ncbi.nlm.nih.gov/pubmed/27714748
  3. https://www.cdc.gov/coronavirus/mers/about/index.html
  4. http://www.who.int/mediacentre/factsheets/mers-cov/en/
  5. http://www.sciencedirect.com/science/article/pii/S1879625716000079
  6. http://www.sciencedirect.com/science/article/pii/S1319562X16000668
  7. Al-Tawfiq JA, Memish ZA. The Middle East Respiratory Syndrome Coronavirus Respiratory Infection: An Emerging Infection from the Arabian Peninsula. In: Kon K, Rai M, editors. The Microbiology of Respiratory System Infections. Academic Press, 2016; pp. 55-63.

Further Reading

Last Updated: Feb 27, 2019

Dr. Tomislav Meštrović

Written by

Dr. Tomislav Meštrović

Dr. Tomislav Meštrović is a medical doctor (MD) with a Ph.D. in biomedical and health sciences, specialist in the field of clinical microbiology, and an Assistant Professor at Croatia's youngest university - University North. In addition to his interest in clinical, research and lecturing activities, his immense passion for medical writing and scientific communication goes back to his student days. He enjoys contributing back to the community. In his spare time, Tomislav is a movie buff and an avid traveler.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Meštrović, Tomislav. (2019, February 27). Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Overview. News-Medical. Retrieved on July 22, 2024 from https://www.news-medical.net/health/Middle-East-Respiratory-Syndrome-Coronavirus-(MERS-CoV)-Overview.aspx.

  • MLA

    Meštrović, Tomislav. "Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Overview". News-Medical. 22 July 2024. <https://www.news-medical.net/health/Middle-East-Respiratory-Syndrome-Coronavirus-(MERS-CoV)-Overview.aspx>.

  • Chicago

    Meštrović, Tomislav. "Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Overview". News-Medical. https://www.news-medical.net/health/Middle-East-Respiratory-Syndrome-Coronavirus-(MERS-CoV)-Overview.aspx. (accessed July 22, 2024).

  • Harvard

    Meštrović, Tomislav. 2019. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Overview. News-Medical, viewed 22 July 2024, https://www.news-medical.net/health/Middle-East-Respiratory-Syndrome-Coronavirus-(MERS-CoV)-Overview.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody